Semler Scientific Inc
NASDAQ:SMLR

Watchlist Manager
Semler Scientific Inc Logo
Semler Scientific Inc
NASDAQ:SMLR
Watchlist
Price: 63.65 USD -4.18% Market Closed
Market Cap: 462.7m USD
Have any thoughts about
Semler Scientific Inc?
Write Note

Semler Scientific Inc
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Semler Scientific Inc
Income from Continuing Operations Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
Semler Scientific Inc
NASDAQ:SMLR
Income from Continuing Operations
$15.9m
CAGR 3-Years
-9%
CAGR 5-Years
3%
CAGR 10-Years
N/A
Becton Dickinson and Co
NYSE:BDX
Income from Continuing Operations
$1.7B
CAGR 3-Years
2%
CAGR 5-Years
8%
CAGR 10-Years
4%
Boston Scientific Corp
NYSE:BSX
Income from Continuing Operations
$1.8B
CAGR 3-Years
16%
CAGR 5-Years
12%
CAGR 10-Years
20%
Stryker Corp
NYSE:SYK
Income from Continuing Operations
$3.6B
CAGR 3-Years
24%
CAGR 5-Years
14%
CAGR 10-Years
19%
Abbott Laboratories
NYSE:ABT
Income from Continuing Operations
$5.8B
CAGR 3-Years
-7%
CAGR 5-Years
12%
CAGR 10-Years
14%
Intuitive Surgical Inc
NASDAQ:ISRG
Income from Continuing Operations
$2.3B
CAGR 3-Years
10%
CAGR 5-Years
12%
CAGR 10-Years
18%
No Stocks Found

Semler Scientific Inc
Glance View

Market Cap
453.2m USD
Industry
Health Care

Semler Scientific, Inc. engages in the provision of technology and software solutions to improve the clinical effectiveness of healthcare providers. The company is headquartered in Santa Clara, California and currently employs 124 full-time employees. The company went IPO on 2014-02-27. The firm develops, manufactures, and markets products and services that assist its customers in evaluating and treating chronic diseases. Its vascular testing product, QuantaFlo, measures arterial blood flow in the extremities to aid in the diagnosis of peripheral arterial disease (PAD). QuantaFlo is a four-minute in-office blood flow test. Healthcare providers can use blood flow measurements as part of their examinations of a patient's vascular condition, including assessments of patients who have vascular disease. The company also has a distribution arrangement for the United States, including Puerto Rico, to distribute Insulin Insights, a software solution designed to provide insulin dosing recommendations to clinicians for the adjustment and maintenance of blood. The firm's customers for QuantaFlo include insurance plans, physician groups, and risk assessment groups.

SMLR Intrinsic Value
17.5 USD
Overvaluation 73%
Intrinsic Value
Price

See Also

What is Semler Scientific Inc's Income from Continuing Operations?
Income from Continuing Operations
15.9m USD

Based on the financial report for Sep 30, 2024, Semler Scientific Inc's Income from Continuing Operations amounts to 15.9m USD.

What is Semler Scientific Inc's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 5Y
3%

Over the last year, the Income from Continuing Operations growth was -19%. The average annual Income from Continuing Operations growth rates for Semler Scientific Inc have been -9% over the past three years , 3% over the past five years .

Back to Top